==== Front Am J Case RepAm J Case RepamjcaserepThe American Journal of Case Reports1941-5923International Scientific Literature, Inc. 2999167510.12659/AJCR.910060910060ArticlesPractical Suggestions for Prevention of Complications Arising from Oxidized Cellulose Retention: A Case Report and Review of the Literature Piozzi Guglielmo Niccolò ABCDEF1Reitano Elisa AE1Panizzo Valerio BCD2Rubino Barbara BCD3Bona Davide CD2Tringali Domenico BCE2Micheletto Giancarlo ABCD24 1 Department of General Surgery, University of Milan, Milano, Italy 2 Department of General Surgery, Istituto Clinico Sant’Ambrogio, Milano, Italy 3 Department of Pathology, IRCCS Policlinico San Donato Hospital, San Donato Milanese, Italy 4 Department of Medical and Surgical Pathophysiology and Transplantation, Policlinico Hospital, Milano, ItalyAuthors’ Contribution: A Study Design B Data Collection C Statistical Analysis D Data Interpretation E Manuscript Preparation F Literature Search G Funds Collection Conflict of interest: None declared Corresponding Author: Guglielmo Niccolò Piozzi, e-mail: guglielmopiozzi@gmail.com2018 11 7 2018 19 812 819 19 3 2018 26 4 2018 © Am J Case Rep, 20182018This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)Patient: Male, 51 Final Diagnosis: Oxidised cellulose retain Symptoms: Abdominal pain • nausea • vomiting Medication: — Clinical Procedure: Laparoscopic abdominal exploration and drainage Specialty: Surgery Objective: Challenging differential diagnosis Background: Bleeding is a major intraoperative complication during surgical procedures. When conventional methods such as ligature and diathermocoagulation are ineffective for bleeding management, hemostatic agents should be used. Oxidized cellulose is one of the major hemostatic agents used worldwide. Oxidized cellulose is often left in situ after hemostasis because of its high level of reabsorption that lasts up to 8 weeks. However, 38 cases of retaining-associated complications are reported in the literature. Case Report: A 51-year-old male patient presented in our emergency department with acute abdominal pain, nausea, and vomiting. The patient had been admitted in our department for laparoscopic cholecystectomy for acute cholecystitis 25 months previously. Abdominal ultrasound and CT scan showed the presence of a cystic circular mass, with homogeneous fluid content, close to the surgical clips of the previous surgery, resembling a “neo-gallbladder”. Laparoscopic abdominal exploration and drainage were performed. Histological examination reported protein-based amorphous material with rare lymphocytes and macrophages. Culturing was negative for bacterial growth. The patient was discharged uneventfully on the 4th postoperative day. The primary surgical report was evaluated with evidence of application of Gelita-Cel® Standard for hemostatic purposes. Results of 12-month follow-up were normal. Conclusions: Herein, we report the first case of a complication associated with the use of Gelita-Cel® Standard. We reviewed the literature to better define the purpose and limits of oxidized cellulose use as a hemostatic agent. Despite the fundamental role of oxidized cellulose as a hemostatic agent, we provide some practical suggestions to prevent the reported severe complications and surgical overtreatments. MeSH Keywords: Cellulose, OxidizedCholecystectomy, LaparoscopicDiagnosis, DifferentialHemostasis, SurgicalPostoperative Complications ==== Body Background Successful hemostasis has always been fundamental in all surgical procedures. Ligature and diathermocoagulation are the main hemostatic methods; however, since 1909, with the use of fibrin [1], numerous hemostatic agents (HA) have become available. In 1945, oxidized cellulose (OC) was introduced in surgery and it has become one of the major HAs because of its ease of use, favorable biocompatibility, and bactericidal properties [2–4]. Several OCs are available and classified in regenerated oxidized cellulose (ROC; e.g. Surgicel® – Johnson and Johnson, Somerville, NJ, USA) and non-regenerated oxidized cellulose (nROC; e.g., Oxycell® – Becton Dickinson, Franklin Lakes, NJ, USA). Although the manufacturers recommend the OC removal after its use, it is generally left in situ because of its high level of reabsorption that lasts up to 8 weeks. However, several cases of retained OC with severe complications have been reported in the literature. Here, we describe a complication that was associated with the use of Gelita-Cel® Standard (ROC; Gelita Medical, Eberbach, Germany) and we review the literature to better define the purpose and limits of OC as a hemostatic agent. Case Report A 51-year-old male patient presented in our emergency department with acute abdominal pain, nausea, and vomiting. Laboratory test results were normal with no evidence of inflammation markers (white blood cells: 8.03×103/µl; neutrophils: 68.2%; C reactive protein: 3 mg/l). He had been admitted to our department for laparoscopic cholecystectomy for acute cholecystitis 25 months previously. The patient complained of moderate abdominal pain since his first operation; therefore, he had abdominal CT scan at 6 months, showing evidence of a circular mass (39×34 mm) with fluid content (density 35–45 HU). In addition, an abdominal US at 24 months showed a non-vascularized mass in the liver bed that was suspected to be a granuloma. The patient was admitted for an abdominal CT scan and the results confirmed a circular cystic mass with homogeneous fluid content, close to the surgical clips of the previous surgery, resembling a “neo-gallbladder” (Figure 1). Although the patient had no signs of inflammation or infection, a hepatic abscess was suspected based on imaging results and previous surgical history. To better define the patient’s unclear clinical condition, we chose to perform a surgical drainage instead of a percutaneous (US- or CT-guided). Therefore, the patient underwent laparoscopic abdominal exploration, incision of the hepatic bed mass, and drainage of amorphous, brown, dense material (Figure 2). A drain was left in the liver bed and was removed on the 2st postoperative day. Histological examination reported protein-based amorphous material with rare lymphocytes and macrophages. Culturing was negative for bacterial growth. After antibiotic prophylaxis with extended spectrum B-lactam, the patient was discharged without symptoms on the 4th postoperative day. The primary surgical report was evaluated for evidence of use of Gelita-Cel® Standard for hemostatic purposes. The 12-month follow-up was uneventful. Discussion Bleeding can be a major intraoperative complication during surgical procedures. When conventional methods such as ligature and diathermocoagulation are ineffective for bleeding management, hemostatic agents (HA) can be used. In 1909, fibrin was described as an effective HA [1] and since then numerous hemostatic devices have been used such as topical thrombin, porcine collagen, and OC [5]. OC was first used for medical purposes in 1945 [2,3], and since then it has been widely used in surgery, with several forms available. OC is easy to use and has good biocompatibility and bactericidal properties [4]. OC is made of cellulose, which is a homopolysaccharide of glucopyranose polymerized through β-glucosidic bonds [6,7]. Cellulose can be either regenerated to form organized fibers or non-regenerated with unorganized fibers prior to oxidation. When cellulose fibres are oxidized, conversion of hydroxyl groups to carboxylic acid groups occurs, yielding polyuronic acid [6,7]. The low pH of the carboxylic acid groups is responsible for several actions: primary local hemostyptic action, secondary platelet activation to form a temporary platelet plug [6,7], and hostile acidic environmental conditions for bacterial survival [8]. Moreover, the knit structure and thickness of the gauge is responsible for bactericidal properties, with thinner loose-knit patterns being less effective than thicker tight-knit patterns against antibiotic-resistant microorganisms [9]. Oxidized regenerated cellulose (ROC) is a re-absorbable material that can be intentionally left in the surgical field. In vivo studies on rats were performed to analyze the tissue reaction to locally implanted hemostatic agents [10]. ROC absorption starts after 24–48 h; at day 7 the gauze is surrounded by inflammatory granulation tissue, and complete degradation occurs between 4–8 weeks [6,10,11]. However, absorption is not always complete, with consequent gauze retention as first described by Vanderhoof et al. [12]. Therefore, it is common for ROC to appear as a mass during the immediate postoperative period, mimicking a postoperative abscess [13], tumor [14], or hematoma [15], posing a serious challenge in differential diagnosis [16]. On CT scan, a retained OC may appear as a mixed- or low-attenuation mass containing a focal central collection of gas, located inside or near the operative site, with a faint enhancement at the mass periphery and absence of air-fluid levels [13,17,18] (Table 1). Over time, the central collection of air is completely replaced by soft tissue, leading to the formation of a foreign-body granuloma [13]. MRI findings are nonspecific, but the presence of hypoin-tense stripes inside a cystic-like cavity on T2-weighted images is considered to be a characteristic sign of ROC-associated granuloma [19]. PET/CT images may produce false-positive results in case of foreign body granuloma as a consequence of localized inflammation, mimicking malignant tissue glucose uptake [20–22]. Retained OC is frequently found in ultrasound imaging (US) as a complex mass or well-encapsulated hypo-isoechoic lesion with circumscribed margins and internal hyperechoic nodules at the surgical site [23]. The presence of hyper-isoechoic nodules within a complex cystic mass can be explained as typical granulomatous foreign body reaction induced by the presence of ROC and was described by Giuliani et al. as “ileflottante” [23,24]. Moreover, the use of color/power Doppler should be considered as part of the ultrasound procedure. A perilesional vascularization is probably indicative of compression exerted by OC on neighboring tissues or connected to the presence of granulation tissue around the surgical site [25,26]. Nevertheless, imaging can be useful and clinical evaluation is fundamental in confirming diagnostic suspicion. We reviewed the literature and retrieved a total of 28 papers comprising 38 cases of OC retention. The details of cases are shown in Table 2. Surgical sites included: brain (6), cervical spine (1), thoracic spine (1), thorax (10), abdomen (12), and pelvis (8). Twenty-nine patients received Surgicel ®, 2 received Oxycel®, 1 received Surgiflo® (Johnson and Johnson, Somerville, NJ, USA), and 6 received non-specified OC (Table 2). Here, we report the first case of complications due to Gelita-Cel® retention. The preoperative diagnosis and surgical procedure are described in Table 2. The times from primary surgery to detection of retained OC ranged between 2 hours and 630 days. Twelve cases were incidental and the others were symptomatic. Various symptoms were described, ranging from malaise and fever to paraplegia, cauda equina syndrome, and vision impairment. Diagnostic suspicion was tumor recurrence (6), abscess (7), cord compression (6), granuloma (4), extradural mass (3), heterogeneous mass (3), gas collection (2), kidney tumor (2), ovarian cancer (1), hematoma (1), abscess/hematoma (1), granuloma/neoplasm (1), and non-specified lesion (1). Gauze removal was performed in 27 cases. In 2 patients, removal of the gauze required a major procedure: 1 patient underwent nephrectomy and another had allograft extirpation that resulted in need for dialysis. Despite the fundamental importance of OC as an essential hemostatic agent in surgery, some precautions are needed to avoid future complications. Although 38 cases, in addition to our reported case, are very few compared to all surgical procedures performed with OC use with no associated complication, complications may also be severe and associated with risky surgical procedures. Our review of the literature found that 8 patients experienced paraplegia, which occurred between 2 hours and 2 days after thoracic surgery [27–29]; cord compression was suspected and urgent laminectomy was performed, revealing a mass of Surgicel® in the extradural space. A surgical report showed the use of OC to control difficult bleeding from the posterior angle of the thoracotomy incision. The posterior end of the rib adjacent to the gaping thoracostomy is usually a bleeding site that is hard to manage. During thoracostomy closure, the rib approximation may produce a compressive force on the OC, forcing it to migrate into the adjacent foramen. The established negative pressure of the intravertebral subdural space can enhance this pressure gradient and cause OC herniation with consequent symptomatology [26]. Product information warns against leaving OC in situ next to foramina after hemostasis due to swelling, which can result in nerve damage due to pressure in a bony confined area [30]. However, there is no report regarding the potential of material migration. Five out of 6 patients presented with total motor and sensory deficit, with extension according to the cord compression site [27–29]: one had spastic monoplegia involving the right leg [28], one patient has to use a cane to walk [27], and one has walking impairment requiring leg braces and obligatory catheterization [27]. In circumstances requiring extensive dissection in the costovertebral angle, precise technique is imperative. Uncontrolled or poorly controlled bleeding in an intervertebral foramen should be an indication for consultation of a neurological surgeon. Dutton et al. [32] reported a case of compressive optic neuropathy after OC migration from the anterior cranial fossa into the orbital apex through an orbital roof fracture. Banerjee et al. [33] reported a case of cauda equina syndrome treated with OC removal and consequent severe impairment of quality of life. To avoid major complications, particular attention must be paid to hemostatic control in rigid inextensible anatomical structures such as the skull and spinal cord. In 9 cases, tumor mass or neoplasm recurrence was suspected, with consequent resective treatment. Somani et al. [34] reported a case of clinically/radiologically suspected renal cell carcinoma in a patient who previously underwent splenectomy for myelofibrosis, evidenced as an heterogenous kidney mass formation on abdominal CT scan with paraortic lymph-adenopathy. Nephrectomy was performed, but histology did not show a neoplasm and instead found a foreign-material granuloma. This is an important case of retained OC mimicking a neoplasm. Azmy et al. [35] reported a case of OC removal in a patient suspected to have a recurrence of neuroblastoma. Royds et al. [36] documented the first case of local tissue reaction associated with Surgicel® in head and neck surgery, with removal and resolution confirming its cause. Concha et al. [37] reported a case of xanthogranulomatous pyelonephritis caused by OC retention in a renal allograft, with consequent extirpation of the allograft and return to dialysis in a 41-year-old patient. Arnold et al. [38] documented an abscess mimicking a mass following cholecystectomy and liver biopsy. Among all 38 cases described, plus our reported case, 11 patients were treated conservatively due to suspicion of an OC-retaining lesion after surgical history evaluation and multidisciplinary analysis by surgeons and radiologists. Although retained OC has been described by many authors [27–29,31,32,34–56], we believe it is important to focus on the cases in which there were severe complications in order to form some conclusions and recommendations The manufacturers recommend OC removal after hemostasis is obtained. If the surgeon decides to leave an OC gauze in situ, it should be used sparingly, as many problems have been attributed to excessive use [45]. If OC is left in situ, the surgical report and the discharge document should state it in order to correctly inform the patient in detail about this condition. In surgical procedures in rigid inextensible anatomical structures as the skull, spinal cord, and pleural cavity (in proximity to the spine), OC should be used with extreme care and, if possible, neurosurgical support should be used for better and safer hemostasis [32] (Table 3). Moreover, when a mass is observed, accurate imaging evaluation and surgical history are required to assess a possible retained granulomatous lesion and to provide the best medical/surgical treatment. Further studies are needed to determine if layer versus coiled disposal of oxidized cellulose may have a role in complications and to assess whether fibrillar oxidized cellulose is safer than the gauze form. Our surgical case report is fully compliant with the SCARE criteria [57]. Conclusions Bleeding is a major intraoperative complication during surgical procedures. OC is an effective aid in hemostasis when ligature and diathermocoagulation are ineffective. Despite biocompatibility and reabsorption, cases of retained OC complications have been described in the literature. OC should be removed when hemostasis is obtained. If necessary, only a small quantity of OC should be placed in situ and it should be documented in the surgical report and the discharge document in order to correctly inform the patient. Accurate surgical history evaluation should always be performed, and multidisciplinary case evaluation between surgeons and radiologists should be done to achieve a more accurate diagnosis and prevent unnecessary revision surgery or further medical and/or surgical interventions. In case of surgical procedures with hemostatic control in rigid inextensible anatomical structures such as the skull and spinal cord, OC should be used with extreme care in order to avoid major complications and, if possible, neurosurgical support should be used for better and safer hemostasis. We also presented the first case of a complication following Gelita-Cel® retention in a case of “neo-gallbladder”. Our aim here is not to criticize the use of OC as hemostatic agent – it has well-documented effectiveness in surgery – but rather to provide some practical suggestions on how to avoid the severe complications reported in the literature. Conflicts of interest None. Figure 1. Cystic lesion with homogeneous fluid content close to surgical clips resembling a “neo-gallbladder” (white arrow). Figure 2. (A) Intraoperative image of “neo-gallbladder”; (B) drainage of amorphous material. Table 1. Imaging features of OC retention. Technique Main characteristics US – Complex mass – Well-encapsulated hypoisoechoic lesion – Circumscribed margins – Internal hyperechoic nodules (“ile-flottante”) – Perilesional vascularization (Doppler) CT scan – Mixed-/low-attenuation mass – Focal central collection of gas – Absence of air-fluid levels – Peripherical faint enhancement – Proximity to the surgical site MRI – Nonspecific – Hypointense stripes inside cystic-like cavity on T2 PET/CT – Image with high glucose uptake – False-positive Table 2. Reported cases of OC retaining complications in the literature. Author Year Age Sex Device Surgical Site Primary diagnosis Primary surgery Time (days) Symptoms Suspect Removal Dutton et al. [32] 1983 35 M Surgicel Brain Head injury Frontotemporal skull and lacerated left frontal lobe repair 2,5 h Vision impairment Hematoma Yes Perez-Guerra et al. [31] 1984 59 F Surgicel Thorax Squamous cell carcinoma Left pneumonectomy 2 h Paraplegia Cord compression Yes Ito et al. [39] 1989 n.a. n.a. OC Brain Intracranial meningioma Intracranial meningioma removal 390 Incidental Large granuloma Yes Ito et al. [39] 1989 n.a. n.a. OC Brain Intracranial meningioma Intracranial meningioma removal 630 Incidental Large granuloma Yes Ito et al. [39] 1989 n.a. n.a. OC Brain Anterior communicating artery aneurysm Vascular treatment n.a. Incidental Large granuloma Yes Short [28] 1990 72 F OC Thorax Bronchogenic carcinoma Right upper/middle lobectomy few days Paraplegia Cord compression Yes Short [28] 1990 49 M OC Thorax Lung adenocarcinoma Right upper lobectomy 2 Paraplegia Cord compression Yes Short [28] 1990 59 M OC Thorax Bronchogenic carcinoma Right lower lobectomy 3,5 h Paraplegia Cord compression Yes Bradley et al. [40] 1991 58 M Oxycel Abdomen Cholecystitis Cholecystectomy 120 Incidental Abscess/Hematoma No Deger et al. [41] 1995 71 F Surgicel Abdomen Ovary serous adenocarcinoma Ovariectomy 150 Abdominal discomfort Tumor recurrence Yes Sandhu et al. [42] 1996 n.a. n.a. Surgicel Brain Intracranial meningioma Intracranial meningioma removal 60 Incidental Tumor recurrence Yes Sandhu et al. [42] 1996 n.a. n.a. Surgicel Brain Intracranial meningioma Intracranial meningioma removal 360 Incidental Tumor recurrence Yes Iwabuchi et al. [43] 1997 46 F Surgicel Thorax n.a. Right lower lobectomy 1 Paraplegia n.a. Yes Concha et al. [37] 1997 41 F Surgicel Abdomen Kidney failure Kidney transplant 570 Fever, abdominal pain, renal function impairment Granuloma/neoplasia Yes, allograft extirpation Banerjee et al. [44] 1998 28 M Surgicel Spinal Disk degeneration, spinal stenosis Spinal decompression 2 Cauda equina syndrome Cord compression Yes Lovstad et al. [29] 1999 56 F Surgicel Thorax Lung tumor Left lower lobectomy 2,5 h Paraplegia Cord compression Yes Azmy [35] 2001 2 M Surgicel Abdomen Neuroblastoma Right adenectomy 4 Incidental Tumor recurrence Yes Ibrahim et al. [45] 2002 53 F Surgicel Thorax Aortic root aneurysm Aortic root replacement 42 Incidental Abscess Yes Gao et al. [46] 2002 37 F Surgicel Pelvic Hemoperitoneum, ruptured corpus luteum Hysterectomy, right salpingo-oophorectomy 30 Abdominal pain, vaginal discharge Granuloma Yes Brodbelt et al. [27] 2002 37 F Surgicel Thorax Metastatic sarcoma Lung lobectomy 1 Paraplegia Extradural mass No Brodbelt et al. [27] 2002 50 M Surgicel Thorax Thoracic trauma Thoracic surgery 3 Weakness/numbness right leg Extradural mass Yes Brodbelt et al. [27] 2002 15 (m) M Surgicel Thorax n.a. Cardiac surgery 2 Flaccid paraparesis, extradural mass Extradural mass Yes Farina Perez et al. [47] 2004 63 F Surgicel Abdomen Renal cell carcinoma Laparoscopic partial necrectomy 8 Incidental Gas collection No Somani et al. [34] 2005 62 F Surgicel Abdomen Myelofibrosis Splenectomy 540 Renal tumor suspect Kidney tumor Yes, necrectomy Arnold et al. [38] 2007 55 M Surgicel Abdomen n.a. Cholecystectomy 4 Abdominal pain Postoperative abscess No Salmo et al. [48] 2009 n.a. M Oxycel Abdomen Rectal cancer Colon resection 90 Incidental Tumor recurrence Yes Agarwal et al. [49] 2010 47 M Surgicel Abdomen Renal cyst Laparoscopic nephron-sparing surgery 90 Incidental Kidney mass No Royds et al. [36] 2012 56 F Surgicel Cervical Multinodular goiter Total thyroidectomy 30 Wound swelling Suture abscess Yes Tefik et al. [50] 2012 50 F Surgicel Abdomen Cystic papillary renal cell carcinoma Laparoscopic nephron-sparing surgery 180 Incidental Heterogeneous mass Yes Wang et al. [51] 2013 83 M Surgicel Abdomen GIST Recurrent GIST 120 GIST recurrence Heterogeneous mass Yes Behbehani et al. [52] 2013 47 F Surgicel Pelvic Uterine leiomyoma Laparoscopic total hysterectomy, bilateral salpingo-oophorectomy 21 Pelvic pain, fever Postoperative abscess No Behbehani et al. [52] 2013 46 F Surgicel Pelvic Uterine leiomyoma and adenomyosis Laparoscopic total hysterectomy 10 Abdominal pain, fever Postoperative abscess Yes Tam et al. [53] 2014 50 F Surgicel Pelvic Endometriosis Laparoscopic hysterectomy 6 Pelvic pain Gas collection No Tam et al. [53] 2014 45 F Surgicel Pelvic Endometriosis Robotic-assisted laparoscopic hysterectomy, left salpingo-oophorectomy, right salpingectomy, appendectomy 10 Abdominal pain, vaginal discharge Abscess No Tam et al. [53] 2014 43 F Surgicel Pelvic Endometriosis Laparoscopic hysterectomy, left oophorectomy, bilateral salpingectomy 4 Malaise Abscess No Zhang et al. [54] 2015 21 F Surgicel Pelvic Symptomatic ovarian cyst Ovarian cystectomy 7 Pelvic pain Heterogeneous mass No Cormio et al. [55] 2016 67 F Surgicel Pelvic Cystocele, anterior genital prolapse Pubovaginal sling, cystocele repair 180 Irritative voiding symptoms Ovarian cancer Yes Singh et al. [56] 2016 71 M Surgiflo Abdomen Clear cell carcinoma Left robotic partial nephrectomy 30 Nodular lesion Recurrence/residual tumor No Table 3. Practical suggestions for safe use of OC. Practical suggestion – Remove OC after hemostasis – If left in situ, use it sparingly – Report the use of OC in the surgical report – Inform the patient about OC retention – Use extreme care in rigid non-extensive anatomical structures (eventual neurosurgical aid) – Accurate surgical history evaluation ==== Refs References: 1. Hong YM Loughlin KR The use of hemostatic agents and sealants in urology J Urol 2006 176 2367 74 17085103 2. Frantz VK Lattes R Oxidized cellulose-absorbable gauze (cellulosic acid) JAMA 1945 129 798 801 3. Frantz VK Absorbable cotton, paper and gauze: (Oxidized cellulose) Ann Surg 1943 118 116 26 17858245 4. Lewis KM Spazierer D Urban MD Comparison of regenerated and non-regenerated oxidized cellulose hemostatic agents Eur Surg 2013 45 213 20 23950762 5. Spotnitz WD Burks SG Hemostats, sealants, and adhesives II: Update as well as how and when to use the components of the surgical toolbox Clin Appl Thromb Hemost 2010 16 497 514 20699255 6. Pierce AM Wiebkin OW Wilson DF Surgicel: Its fate following implantation J Oral Pathol 1984 13 6 661 70 6440959 7. Miller JM Jackson DA Collier CS An investigation of the chemical reactions of oxidized regenerated cellulose Exp Med Surgery 1961 19 196 201 8. Dineen P The effect of oxidized regenerated cellulose on experimental infected splenotomies J Surg Res 1977 23 114 16 886839 9. Spangler D Rothenburger S Nguyen K In vitro antimicrobial activity of oxidized regenerated cellulose against antibiotic-resistant microorganisms Surg Infect 2003 4 255 62 10. Alpaslan C Alpaslan GH Oygur T Tissue reaction to three subcutaneously implanted local hemosatic agents Br J Oral Maxillofac Surg 1997 35 129 32 9146872 11. Mayank M Agarwal MM Mandal AK Surgicel granuloma: Unusual cause of recurrent mass lesion after laparoscopic nephron-sparing surgery for renal cell carcinoma Urology 2010 76 334 35 20494418 12. Vanderhoof ES Merendino KA Unfavorable reactions to oxidized cellulose in the bed of the gallbladder; the retained Oxycel sponge syndrome Arch Surg 1949 58 182 88 18111733 13. Young ST Paulson EK McCann RL Baker ME Appearance of oxidized cellulose (Surgicel) on postoperative CT scans: Similarity to postoperative abscess Am J Roentgenol 1993 160 275 77 8424333 14. Sandhu GS Elexpuru-Camiruaga JA Buckley S Oxidized cellulose (Surgicel) granulomata mimicking tumour recurrence Br J Neurosurg 1996 10 617 19 9115663 15. van Gelderen F Swinnen J Appearance of oxidized cellulose (Surgicel) on abdominal radiographs Am J Roentgenol 1996 167 1593 16. Kim SR Baik HK Park YW Retained surgical sponge presenting as a pelvic tumor after 25 years Int J Gynaecol Obstet 2003 82 223 25 12873788 17. O’Connor AR Coakley FV Meng MV Eberhardt SC Imaging of retained surgical sponges in the abdomen and pelvis Am J Roentgenol 2003 180 481 89 12540456 18. Mausner EV Yitta S Slywotzky CM Bennett GL Commonly encountered foreign bodies and devices in the female pelvis: MDCT appearances Am J Roentgenol 2011 196 W461 70 21427312 19. Oto A Remer EM O’Malley CM MR characteristics of oxidized cellulose (Surgicel) Am J Roentgenol 1999 172 1481 84 10350276 20. Yuh-Feng T Chin-Chu W Cheng-Tau S Min-Tsung T FDG PET CT features of an intraabdominal gossypiboma Clin Nucl Med 2005 30 561 63 16024957 21. Ghersin E Keidar Z Brook OR A new pitfall on abdominal PET/CT: A retained surgical sponge J Comput Assist Tomogr 2004 28 839 41 15538161 22. Vertechy L di Francesco L Musella A Nonabsorbable suture granuloma mimicking ovarian cancer recurrence at combined positron emission tomography/computed tomography evaluation: A case report J Med Case 2014 8 202 23. Giuliani M Fubelli R Patrolecco F Mammographic and ultrasonograph -ic findings of oxidized regenerated cellulose in breast cancer surgery: A 5-year experience. Clin Breast Cancer 2015 15 5 e249 56 25922282 24. Kwag H Imaging findings of implanted absorbable mesh in patients with breast partial resection Yonsei Med J 2008 49 111 18 18306477 25. Bäz E Madjar H Reuss C The role of enhanced Doppler ultrasound in differentiation of benign vs . malignant scar lesion after breast surgery for malignancy Ultrasound Obstet Gynecol 2000 15 377 82 10976477 26. Stuhrmann M Aronius R Schietzel M Tumor vascularity of breast lesions: Potentials and limits of contrast-enhanced Doppler sonography Am J Roentgenol 2000 175 1585 89 11090380 27. Brodbelt AR Miles JB Foy PM Broome JC Intraspinal oxidized cellulose (Surgicel) causing delayed paraplegia after thoracotomy – a report of three cases Ann R Coll Surg Engl 2002 84 2 97 99 11995773 28. Short HD Paraplegia associated with the use of oxidized cellulose in posterolateral thoracotomy incisions Ann Thorac Surg 1990 50 2 288 89 2200364 29. Løvstad RZ Steen PA Forsman M Paraplegia after thoracotomy – not caused by the epidural catheter Acta Anaesthesiol Scand 1993 43 2 230 32 30. Ordell NJ Physician’s desk reference Medical Economics Company, Inc 1989 1058 31. Perez-Guerra F Holland JM Epidural hematoma as a cause of postpneumonectomy paraplegia Ann Thorac Surg 1985 39 3 282 3977474 32. Dutton JJ Tse DT Anderson RL Compressive optic neuropathy following use of intracranial oxidized cellulose hemostat Ophthalmic Surg 1983 6 487 89 33. Banerjee T Goldschmidt K ‘Surgiceloma’ manifested as cauda equina syndrome South Med J 1998 91 5 481 83 9598861 34. Somani BK Kasthuri RS Shave RM Emtage LA Surgicel granuloma mimicking a renal tumour Surgery 2006 139 3 451 16546514 35. Azmy AF Oxidized cellulose haemostat mimicking a possible recurrence of neuroblastoma BJU Int 2001 88 3 295 96 11488748 36. Royds J Kieran S Timon C Oxidized cellulose (Surgicel) based reaction post thyroidectomy mimicking an abscess: A case report Int J Surg Case Rep 2012 3 7 338 39 22572542 37. Concha A Esteban RJ Talavera P Xanthogranulomatous pyelonephritis caused by Surgical in a renal allograft Nephrol Dial Transplant 1997 12 7 1509 11 9249801 38. Arnold AC Sodickson A Postoperative Surgicel mimicking abscesses following cholecystectomy and liver biopsy Emerg Radiol 2008 15 3 183 85 17899231 39. Ito H Onishi H Shoin K Nagatani H Granuloma caused by oxidized cellulose following craniotomy Acta Neurochir 1989 100 1–2 70 73 2816537 40. Bradley M Singh G Case report: An oxidized cellulose granuloma – another hepatic pseudotumour? Clin Radiol 1991 44 3 206 7 1914404 41. Deger RB LiVolsi VA Noumoff JS Foreign body reaction (gossypiboma) masking as recurrent ovarian cancer Gynecol Oncol 1995 56 1 94 96 7821856 42. Sandhu GS Elexpuru-Camiruaga JA Buckley S Oxidized cellulose (Surgicel) granulomata mimicking tumour recurrence Br J Neurosurg 1996 10 6 617 19 9115663 43. Iwabuchi S Koike K Okabe T Iatrogenic paraplegia caused by surgicel used for hemostasis during a thoracotomy: Report of a case Surg Today 1997 27 10 969 70 10870587 44. Banerjee T Goldschmidt K ‘Surgiceloma’ manifested as cauda equina syndrome South Med J 1998 91 5 481 83 9598861 45. Ibrahim MF Aps C Young CP A foreign body reaction to Surgicel mimicking an abscess following cardiac surgery Eur J Cardiothorac Surg 2002 22 3 489 90 12204761 46. Gao HW Lin CK Yu CP Oxidized cellulose (Surgicel) granuloma mimicking a primary ovarian tumor Int J Gynecol Pathol 2002 21 4 422 23 12352194 47. Fariña Pérez LA Delgado C Dos Santos J Oxidized cellulose (Surgicel) mimics an abscess after laparoscopic partial nephrectomy Actas Urol Esp 2004 28 1 54 56 15046482 48. Salmo E Bisset R Aldean I Oxidized cellulose mimicking a recurrent colorectal cancer: Report of a case and review of the literature Colorectal Dis 2010 12 4 381 82 19220373 49. Agarwal MM Mandal AK Agarwal S Surgicel granuloma: unusual cause of “recurrent” mass lesion after laparoscopic nephron-sparing surgery for renal cell carcinoma Urology 2010 76 2 334 35 20494418 50. Tefik T Sanli O Oktar T Oxidized regenerated cellulose granuloma mimicking recurrent mass lesion after laparoscopic nephron sparing surgery Int J Surg Case Rep 2012 3 6 227 30 22472162 51. Wang H Chen P Surgicel® (oxidized regenerated cellulose) granuloma mimicking local recurrent gastrointestinal stromal tumor: A case report Oncol Lett 2013 5 5 1497 500 23759739 52. Behbehani S Tulandi T Oxidized regenerated cellulose imitating pelvic abscess Obstet Gynecol 2013 121 2 Pt 2 Suppl. 1 447 49 23344404 53. Tam T Harkins G Dykes T Oxidized regenerated cellulose resembling vaginal cuff abscess JSLS 2014 18 2 353 56 24960506 54. Zhang F Bonidie MJ Ventrelli SM Furlan A Intraovarian oxidized cellulose (Surgicel) mimicking acute ovarian pathology after recent pelvic surgery Radiol Case Rep 2015 10 4 39 41 26649116 55. Cormio L Cormio G Di Fino G Surgicel® granuloma mimicking ovarian cancer: A case report Oncol Lett 2016 12 2 1083 84 27446398 56. Singh A Jai S Ganpule S Ganpule A Bolster material granuloma masquerading as recurrent renal cell carcinoma following partial nephrectomy Indian J Radiol Imaging 2016 26 3 352 55 27857461 57. Agha RA Fowler AJ Saetta A SCARE Group The SCARE statement: Consensus-based surgical case report guidelines Int J Surg 2016 34 180 86 27613565